Cargando…

Erratum to: Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands

Detalles Bibliográficos
Autores principales:	Dal Ben, Diego, Lambertucci, Catia, Taffi, Sara, Vittori, Sauro, Volpini, Rosaria, Klotz, Karl-Norbert, Cristalli, Gloria
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2006
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096752/ https://www.ncbi.nlm.nih.gov/pubmed/19937422 http://dx.doi.org/10.1007/s11302-006-9025-z

Ejemplares similares

Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands
por: Dal Ben, Diego, et al.
Publicado: (2006)

2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors
por: Volpini, Rosaria, et al.
Publicado: (2005)

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile
por: Lambertucci, Catia, et al.
Publicado: (2007)

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A(2B) adenosine receptor
por: Dal Ben, Diego, et al.
Publicado: (2013)

Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
por: Dal Ben, Diego, et al.
Publicado: (2019)

A(2A) Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
por: Spinaci, Andrea, et al.
Publicado: (2022)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018)

P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
por: Spinaci, Andrea, et al.
Publicado: (2021)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A(2A) Adenosine Receptor Useful in Neurodegenerative Disorders
por: Francucci, Beatrice, et al.
Publicado: (2023)

Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A(1) Receptor Ligands
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17)
por: Zhuo, Tongyou, et al.
Publicado: (2017)

Adenosine Receptors as Neuroinflammation Modulators: Role of A(1) Agonists and A(2A) Antagonists
por: Martí Navia, Aleix, et al.
Publicado: (2020)

The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A(3) Receptor Agonist, in a Rat Model of Colitis
por: Antonioli, Luca, et al.
Publicado: (2020)

Combined Therapy of A(1)AR Agonists and A(2A)AR Antagonists in Neuroinflammation
por: Marucci, Gabriella, et al.
Publicado: (2021)

ERRATUM: Olfactory imprinting is triggered by MHC peptide ligands
por: Hinz, Cornelia, et al.
Publicado: (2014)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
por: Catarzi, Daniela, et al.
Publicado: (2019)

Erratum to: The effects of the adenosine A3 receptor agonist IB-MECA on sodium taurocholate-induced experimental acute pancreatitis
por: Prozorow-Krol, Beata, et al.
Publicado: (2013)

Erratum to: Evaluation of adenosine triphosphate testing for on-farm cleanliness monitoring compared to microbiological testing in an empty pig farrowing unit
por: Yi, Seung-Won, et al.
Publicado: (2022)

Erratum: Distinct loops in arrestin differentially regulate ligand binding within the GPCR opsin
por: Sommer, Martha E., et al.
Publicado: (2012)

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum
Publicado: (2019)

“Dual Anta-Inhibitors” of the A(2A) Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
por: Spinaci, Andrea, et al.
Publicado: (2023)

Erratum to “New Insights into Ligand-Receptor Pairing and Coevolution of Relaxin Family Peptides and Their Receptors in Teleosts”
por: Good, Sara, et al.
Publicado: (2013)

Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs
por: Vazquez-Rodriguez, Saleta, et al.
Publicado: (2020)

Erratum: Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities
por: Rizzo, Angela, et al.
Publicado: (2015)

Erratum to: Novel Hybrid Ligands for Passivating PbS Colloidal Quantum Dots to Enhance the Performance of Solar Cells
por: Yang, Yuehua, et al.
Publicado: (2016)

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
por: Catarzi, Daniela, et al.
Publicado: (2022)

Erratum to: Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand
por: Zerka, Agata, et al.
Publicado: (2015)

Erratum to: Distribution of killer cell immunoglobulin-like receptors(KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2010)

Erratum to: Evaluation of an online training program in eating disorders for health professionals in Australia
por: Brownlow, Rachel S., et al.
Publicado: (2016)

Erratum to: Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study
por: Rovisco, João, et al.
Publicado: (2016)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury: Erratum
Publicado: (2023)

Erratum to “Design of Additively Manufactured Lattice Structures for Biomedical Applications”
por: Martorelli, Massimo, et al.
Publicado: (2021)

Erratum: Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands
por: Medina-Carmona, Encarnación, et al.
Publicado: (2016)

Erratum: Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor
por: Freeman, Spencer A., et al.
Publicado: (2015)

Erratum zu: Ocrelizumab zur Behandlung der Multiplen Sklerose
por: Graf, Jonas, et al.
Publicado: (2020)

Erratum: Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
por: Sheng, Jin, et al.
Publicado: (2016)

Erratum
por: Turk, Mary Jo, et al.
Publicado: (2005)

Erratum
Publicado: (2007)

Erratum
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9lqpcemov0p08baubq9qq2no3j